Form 4/A for BCDA BioCardia, Inc.
Accepted 2023-04-14 00:00:00 ET · period of report 2022-05-13 · accession 0001437749-23-010355 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2023-04-14 | 2022-05-13 | BCDA | Altman Peter | Pres, CEO, Dir | A - Grant | $1.37 | -3,498 | 348.9K | -1.0% | -$4,792 |
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-13 | A | D | 3,498 | $1.37 | 348,943 | D | — | — | (F1) The original Form 4 filed on May 13, 2022 incorrectly reported that 2,698 shares were purchased. 3,498 shares were purchased on May 13, 2022 and are correctly reported herein. (F2) This transaction was executed in multiple trades ranging from $1.32 to $1.45 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. (F3) The original Form 4 incorrectly reported that 348,143 shares were beneficially owned following the reported transaction. The corrected amount is reported herein. |